Prostate Cancer: Abiraterone
The question
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential implications for his policies of Northern Ireland being the only part of the UK unable to offer abiraterone routinely to eligible prostate cancer patients.
Answered by Dr Zubir Ahmed
There are no current plans to hold discussions with the Northern Irish Department of Health or the Health and Social Care Board on abiraterone access in Northern Ireland. Decisions on the availability of medicines in Northern Ireland are a matter for the Northern Ireland Executive.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →